Increased thyroid cancer risk in acromegaly

Area of Science:

• Endocrinology and Oncology
• Clinical Medicine

Background:

• Acromegaly, a condition caused by excess growth hormone, is associated with an increased risk of various cancers.
• Understanding the prevalence and predictors of tumors in acromegaly patients is crucial for early detection and management.

Purpose of the Study:

• To determine the prevalence of tumors in patients with acromegaly.
• To identify predictors of malignancy in acromegalic individuals.
• To assess the specific cancer risks, including thyroid, breast, and colorectal cancers, in this population.

Main Methods:

• Retrospective evaluation of 160 acromegaly patients treated between 1990 and 2012.
• Screening included colonoscopy, mammography, and ultrasonography of the thyroid and prostate.
• Logistic regression analysis was used to identify predictors of malignancy.

Main Results:

• Malignancy was detected in 34 (21.3%) of the evaluated patients.
• Thyroid cancer was the most common malignancy (10.6%), followed by breast cancer (2.5%) and colorectal cancer (1.8%).
• Older age at diagnosis of acromegaly was significantly associated with an increased risk of cancer.

Conclusions:

• The prevalence of cancer, especially thyroid cancer, appears to be higher in acromegaly patients than previously reported.
• Older age at diagnosis is a key predictor for malignancy in acromegaly.
• Routine cancer screening, particularly for thyroid cancer, is recommended for all acromegaly patients.